Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis. [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated the safety and effectiveness of Remicade (infliximab) in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED